Cargando…

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study

In this prospective study, a new strategy for the prescription of neoadjuvant chemotherapy (NAC) was prospectively tested and depended on the presence of stemness gene amplifications in the tumor before treatment, which in our early studies showed a connection with metastasis. The study included 92...

Descripción completa

Detalles Bibliográficos
Autores principales:	Litviakov, Nikolai V., Ibragimova, Marina K., Tsyganov, Matvey M., Kazantseva, Polina V., Doroshenko, Artem V., Garbukov, Eugeniy Yu., Frolova, Irina G., Slonimskaya, Elena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151881/ https://www.ncbi.nlm.nih.gov/pubmed/34064798 http://dx.doi.org/10.3390/jpm11050397

Ejemplares similares

Amplifications of stemness genes and the capacity of breast tumors for metastasis
por: Litviakov, Nikolai, et al.
Publicado: (2020)

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
por: Litviakov, Nikolai V., et al.
Publicado: (2016)

Amplification of Stem Genes: New Potential Metastatic Makers in Patients with an Early Form of Breast Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2019)

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis
por: Ibragimova, Marina K., et al.
Publicado: (2022)

Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
por: Denisov, Evgeny V., et al.
Publicado: (2014)

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes
por: Tsyganov, Matvey Mihajlovich, et al.
Publicado: (2022)

Tumour Stem Cells in Breast Cancer
por: Ibragimova, Marina, et al.
Publicado: (2022)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Ibragimova, Marina K., et al.
Publicado: (2021)

Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Human papillomavirus and prostate cancer: systematic review and meta-analysis
por: Tsydenova, Irina A., et al.
Publicado: (2023)

Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
por: Liu, Tengfei, et al.
Publicado: (2018)

CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens
por: Ibragimova, M. K., et al.
Publicado: (2023)

Organ-Specificity of Breast Cancer Metastasis
por: Ibragimova, Marina K., et al.
Publicado: (2023)

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)

Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
por: Tsyganov, Matvey M., et al.
Publicado: (2023)

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023)

Abscopal effect in the radio and immunotherapy
por: Pevzner, Alina M., et al.
Publicado: (2021)

WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells
por: Tsydenova, Irina A., et al.
Publicado: (2023)

Human Papillomavirus in Non-Small Cell Lung Carcinoma: Assessing Virus Presence in Tumor and Normal Tissues and Its Clinical Relevance
por: Tsyganov, Matvey M., et al.
Publicado: (2023)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF
por: Larionova, Irina, et al.
Publicado: (2023)

Insulin-Like Growth Factors and Their Binding Proteins in Tumors and Ascites of Ovarian Cancer Patients: Association With Response To Neoadjuvant Chemotherapy
por: Yunusova, Natalia V, et al.
Publicado: (2016)

Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified
por: Zavyalova, Marina V., et al.
Publicado: (2013)

MALAT1 Long Non-coding RNA and Its Role in Breast Carcinogenesis
por: Tsyganov, M. M., et al.
Publicado: (2023)

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
por: Boeck, S, et al.
Publicado: (2014)

Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy
por: Lu, Xian-Ying, et al.
Publicado: (2022)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019)

Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma
por: Spirina, Liudmila V, et al.
Publicado: (2017)

Photoacoustic Computed Tomography of Breast Cancer in Response to Neoadjuvant Chemotherapy
por: Lin, Li, et al.
Publicado: (2021)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?
por: Ryspayeva, Dinara, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Development of microsatellite loci of pod mahogany, Afzelia quanzensis (Fabaceae), by Illumina shotgun sequencing, and cross-amplification in A. africana(1)
por: Jinga, Percy, et al.
Publicado: (2016)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
por: Herrero-Vicent, C, et al.
Publicado: (2016)

LC3B, mTOR, AMPK Are Molecular Targets for Neoadjuvant Chemotherapy in Gastric Cancers
por: Spirina, Liudmila V., et al.
Publicado: (2022)

Direct Nanoscale Visualization of the Electric-Field-Induced Aging Dynamics of MAPbI(3) Thin Films
por: Emelianov, Nikita A., et al.
Publicado: (2023)

Cross-amplification and characterization of microsatellite loci for the Neotropical orchid genus Epidendrum
por: Pinheiro, Fábio, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ppifnam8r1r6par9r1mp560e9o